Allergic Rhinitis
Conditions
Interventions
The western medicine group:Loratadine tablets are taken orally
Acupuncture of sphenopalatine ganglion group:The sphenoid palatine ganglion was needled with a needle
Tongqiao yifei acupuncture group:The sphenoid palatine ganglion was needled with a needle and moxibustion was performed
Sponsors
Hebei Medical Qigong Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) meeting the diagnostic criteria for allergic rhinitis; (2) aged between 18 and 60 years; (3) not participating in other clinical researchers; (4) voluntarily join the trial and fill in the informed consent form.
Exclusion criteria
Exclusion criteria: (1) patients with other nasal diseases, such as moderate and severe deviation of the nasal septum or formation of nasal polyps; (2) patients who had suffered from acute upper respiratory tract infection within 2 weeks, or were complicated with attack respiratory diseases such as asthma, or presented inflammatory responses on chest X-ray; (3) steroids and antihistamines, h1-antihistamines, antibiotics, decongestants (acting on nose, mouth and eye), etc. were used within 1 week; (4) have received specific immunotherapy or regular hormone therapy within the last year; (5) received other treatment for the disease within two weeks; (6) women who are nursing or pregnant and are preparing for pregnancy during treatment;Severe disease; (7) with other system, such as: severe hypertension, coronary atherosclerotic heart disease, diabetes and other basic diseases of instability, hepatitis, tuberculosis patients or blood creatinine, aspertate aminotransferase/cereal third transaminase (AST/ALT) index exceeds the norm for 2 times, blood coagulation tests suggest with bleeding tendency; (8) mental patients; (9) smoking more than 10 cigarettes a day for more than 10 years; (10) if there is a scar at the site of needle application or there is a systemic disease at the site of needle application that the researcher thinks is not suitable for taking measures; (11) the clinical researcher considers that the subject participating in the clinical study cannot cooperate with the treatment; (12) patients participating in other clinical trials; (13) those who have a history of allergic or adverse reactions to drugs and treatment measures related to this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale;Rhinoconjunctivitis Quality of Life Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient acceptance survey;Investigation on days of recurrence; | — |
Countries
China
Contacts
Public ContactDu Yuanhao
Outcome results
None listed